Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias.

Author: AranaAlejandro, BartschJennifer L, BuiChristine L, FortunyJoan, KayeJames A, MargulisAndrea V, McQuayLisa J, Perez-GutthannSusana, PlanaEstel

Paper Details 
Original Abstract of the Article :
STUDY OBJECTIVE: To estimate the incidence of 10 common cancers among patients treated with antimuscarinic medications for overactive bladder (AMOABs). DESIGN: Retrospective cohort study. DATA SOURCE: United Kingdom's Clinical Practice Research Datalink. PATIENTS: A total of 119,912 adults with n...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518180/

データ提供:米国国立医学図書館(NLM)

Antimuscarinic Medications and Cancer Risk: A Careful Examination

Overactive bladder, a common condition affecting many individuals, can be as frustrating as a persistent sandstorm, disrupting daily life. This study investigated the potential association between antimuscarinic medications, used to treat overactive bladder, and the incidence of several types of cancer. It's like examining the tracks left by a caravan, seeking to understand the potential consequences of its journey.

Protopathic Bias: A Potential Explanation

The study found a higher incidence of bladder and prostate cancer in the year after starting antimuscarinic medication, but this association weakened over time. This is like observing a pattern in the desert landscape that appears to be caused by a caravan, but upon closer inspection, turns out to be a naturally occurring formation. The authors concluded that the observed association was more likely due to protopathic bias, meaning that patients' urinary symptoms, which were actually caused by an underlying cancer, prompted treatment with antimuscarinic medication. It's like mistaking a mirage for a real oasis.

Early Cancer Detection: A Crucial Priority

The study emphasizes the importance of early cancer detection, especially for bladder and prostate cancer. Clinicians should be aware of this potential bias and consider these cancers in patients seeking treatment for overactive bladder. It's like being a vigilant desert traveler, constantly scanning the horizon for signs of potential danger.

Dr.Camel's Conclusion

This study underscores the importance of careful analysis and interpretation of medical data. It's a reminder that correlations do not necessarily imply causation, and we must be cautious about drawing conclusions from observational studies. Like a desert traveler who needs to rely on their own judgment and experience, we must carefully consider all the evidence before forming conclusions.

Date :
  1. Date Completed 2018-04-03
  2. Date Revised 2023-11-04
Further Info :

Pubmed ID

28370075

DOI: Digital Object Identifier

PMC5518180

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.